Southlake Regional Health Centre   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Newmarket Canada (1922)

Organization Overview

First Clinical Trial
2006
NCT00848796
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Southlake Regional Health Centre

Active Ingredients

Drugs in Phase 4 Trials (3)

acetylsalicylic acid (aspirin) (1 trial)

amiodarone (cordarone) (2 trials)

rivaroxaban (xarelto) (1 trial)

Drugs in Phase 3 Trials (1)

warfarin (coumadin) (1 trial)

Drugs in Other Trials (1)

heparin (liquaemin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrial Fibrillation (Phase 4)

Heart Failure (Phase 4)

Thromboembolism (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 5